Dermatological problems of the puberty

Postepy Dermatologii i Alergologii

Volumn 30, Issue 3, 2013, Pages 178-187

  Bergler Czop, Beata ^a   Brzezińska Wcisło, Ligia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acne; Hair; Hyperhidrosis; Puberty

Indexed keywords

ANDROGEN; ANTIANDROGEN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZELAIC ACID; BENZOYL PEROXIDE; FINASTERIDE; ISOTRETINOIN; MINOXIDIL; RETINOID; SALICYLIC ACID;

ACNE; ACNE CONGLOBATA; ACNE CYSTICA; ACNE VULGARIS; ALOPECIA; ANTIANDROGEN THERAPY; ATTITUDE; BODY SURFACE; COMEDONAL ACNE; DRUG MEGADOSE; EGO DEVELOPMENT; FOOT; HAIR DISEASE; HAND; HORMONE DETERMINATION; HUMAN; HYPERHIDROSIS; INGUINAL REGION; MALE TYPE ALOPECIA; MORPHOLOGY; NODULAR ACNE; PAPULOPUSTULAR ACNE; PSYCHOSEXUAL DEVELOPMENT; PSYCHOSOCIAL DEVELOPMENT; PUBERTY; REVIEW; SCALP; SEBACEOUS GLAND; SEBORRHEIC DERMATITIS; SKIN DISEASE; SWEAT GLAND;

EID: 84880104497     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2013.35621     Document Type: Review

References (85)

1. Jenerowicz D, Silny W, Dańczak-Pazdrowska A, et al. Environmental factors and allergic diseases. Ann Agric Environ Med 2012; 19: 475-81.
2. Żukiewicz-Sobczak W, Krasowska E, Zwoliński J, et al. Allergic diseases - current state of knowledge. Postep Derm Alergol 2012; 29: 451-5.
3. Koo JY, Smith LL. Psychologic aspects of acne. Pediatr Dermatol 1991; 8: 185-8.
4. Braun-Falco O, Burgdorf WHC, Plewig G, et al. Dermatology. Czelej, Lublin 2010.
5. Ramos-e-Silva M, Carneiro SC. Acne vulgaris: review and guidelines. Dermatol Nurs 2009; 2: 63-8.
6. James KA, Burkhart CN, Morrell DS. Emerging drugs for acne. Expert Opin Emerg Drugs 2009; 14: 649-59.
7. Shamban AT, Narurkar VA. Multimodal treatment of acne, acne scars and pigmentation. Dermatol Clin 2009; 27: 459-71.
8. Plewig G. How acne vulgaris develops. Hautarzt 2010; 61: 99-100, 102-4, 106.
9. Webster G, Rawlings A. Acne. Diagnostic and treatment. Czelej, Lublin 2009.
10. Thiboutot D, Gollnick H. The modern view of acne treatment: World Group of Experts. Dermatol Cosmetol 2009; 9: 4-52.
11. Thiboutot D. Pathogenesis and treatment of acne. J Eur Acad Dermatol Venerol 2001; 15: 91.
12. Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol 2010; 9: 59-63.
13. Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology 1998; 196: 119-25. (Pubitemid 28116058)
14. Morel P, Vienne MP, Belyot C, et al. Antibiotic sensitivity of Propionibacterium acnes isolates studied in a skin clinic in Singapore. Arch Dermatol 1999; 24: 723.
15. Wolska H. The role of combined therapy in acne treatment. Derm Klin Zabieg 2001; 3: 129.
16. Eady EA. Bacterial resistance in acne. Dermatology 1998; 196: 59-66. (Pubitemid 28116041)
17. Mourelatos K, Eady EA, Cunliffe WJ, et al. Temporal changes in sebum excertion and priopionibacterial colonization in preadolescent children with and without acne. Br J Dermatol 2007; 156: 22-31. (Pubitemid 44924140)
18. Grange PA, Chereau C, Raingeaud J, et al. Production of superoxide anions by keratinocytes initiates P. acnes-induced inflammation of the skin. Plos Pathog 2009; 5: e1000527.
19. Kang BS, Seo JG, Lee GS, et al. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J Microbiol 2009; 47: 101-9.
20. Lyte P, Sur R, Nigam A, et al. Heat-killed Propionibacterium acnes is capable of inducting inflammatory responses in skin. Exp Dermatol 2009; 18: 1070-2.
21. Vega B, Jomard A, Michel S. Regulation of human monocyte Toll-like receptor 2 (TLR2) expression by adapalene. J Eur Acad Dermatol Venerol 2002; 16: 123.
22. Elsaie ML, Choudhary S, Kammer JN. New insights into adolescent acne. G Ital Dermatol Venereol 2009; 144: 645-62.
23. Bergler-Czop B, Brzezi?ska-Wcis?o L. The results of acne conglobata treatment with oral isotretinoin - 10 years observation in patients of Department of Dermatology Silesian Medical University. Dermatol Klin 2005; 2: 73-7. (Pubitemid 40780404)
24. Miller LS. Toll-like receptors in skin. Adv Dermatol 2008; 24: 71-87.
25. Holland KT, Holland DB, Cunliffe WJ, et al. Detection of Propionibacterium acnes polypeptides which have stimulated an immune response in acne patients but not in normal individuals. Exp Derm 1993; 2: 12-6. (Pubitemid 23244482)
26. Melnik BC. FoxO1 - the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges 2010; 8: 105-14.
27. Sarici G, Cinar S, Armutcu F, et al. Oxidative stress in acne vulgaris. J Eur Acad Dermatol Venereol 2010; 24: 763-7.
28. Zoubolis CC, Seltmann H, Hiroi N, et al. Corticotrophin-relasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci 2002; 99: 7148-53. (Pubitemid 34526270)
29. Bergler-Czop B, Brzezi?ska Wcis?o L. Hormonal factors in acne vulgaris. Pol Merkuriusz Lek 2004; 16: 490-2. (Pubitemid 38765127)
30. Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009; 18: 821-32.
31. Lolis MS, Bowe WP, Shalita AR. Acne and systemic disease. Med Clin North Am 2009; 93: 1161-81.
32. Bellew S, Thiboutot D, Del Rosso JQ. Pathogenesis of acne vulgaris. What's new. What's interesting and what may be clinically relevant. J Drugs Dermatol 2011; 1: 582-5.
33. Wolska H, Langner A, Sta̧pór W. Diagnostics and optimalization of acne treatment (acne vulgaris). Medipress 1997; 4: 2-12.
34. Zouboulis CC, Makrantonaki E. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol 2011; 29: 3-14.
35. Brzezińska-Wcisło L, Bergler-Czop B, Wcisło- Dziadecka D. What's new in acne etiology? Dermatol Klin 2006; 4: 275-9.
36. Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? Facts and controversies. Clin Dermatol 2010; 28: 17-23.
37. Ahsan MK, Urano Y, Kato S, et al. Immunohistochemical localisation of thyroid hormone nuclear receptors in human hair folicles and in vitro effect of L-triiodothyronine on cultured cells of hair follicles and skin. Lab Med Invest 1998; 44: 179-84. (Pubitemid 128708042)
38. Bohm M, Schiller M, Brzoska T, et al. Expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002; 118: 533-9. (Pubitemid 34227173)
39. Thiboutot D, Gilliland BS. Androgen methabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 1999; 135: 1041-5. (Pubitemid 29430494)
40. Zaidi Z. Dispelling the myths and misconceptions of acne. J Pak Med Assoc 2009; 5: 264-5.
41. Yang Z, Yu H, Cheng B, et al. Relationship between the CAG repeat polymorphism in the androgen receptor gene and acne in the Han ethnic group. Dermatology 2009; 4: 302-6.
42. Bergler-Czop B, Brzezińska-Wcisło L. Methods of acne treatment in Department of Dermatology Silesian Medical University in years 1991-2000. Wiad Lek 2005; 41: 56-160.
43. Marcason W. Milk consumption and acne: is there a link? J Am Diet Assoc 2010; 110: 152.
44. Allen M, Gratchtchouk M, Sheng H. Hedgehog signaling regulates sebaceous gland development. Am J Path 2003; 163: 2173-8. (Pubitemid 37466461)
45. Hsu P, Litman GI, Brodell RT. Overview of the treatment of acne vulgaris with topical retinoids. Postgrad Med 2011; 123: 153-61.
46. Bergler-Czop B. Early and late results of treatment various kind of acne in Department of Dermatology Silesian Medical University in years 1991-2000. Śla̧ska Akademia Medyczna, Katowice 2003.
47. Laubscher T, Regier L, Jin M, et al. Taking the stress out of acne managment. Can Fam Physician 2009; 55: 266-9.
48. Aldana OL, Holland DB, Cunliffe WJ. Variation in pilosebaceous duct kerationocyte proliferation in acne patients. Dermatology 1998; 196: 98-9. (Pubitemid 28116053)
49. Worobec SM, Wong FA, Tolman EL. Percutaneous absorption of 3H-tretinoin in normal volunteers. J Invest Dermatol 1991; 96: 574A.
50. Kravarusic D, Freud E. Thoracoscopic sympathectomy ganglia ablation in the management of palmer hyperhidrosis: a decade experience in a single institution. Afr J Paediatr Surg 2012; 9: 143-7.
51. Dressler D. Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system. J Neurol 2012; 8: 193-5.
52. Hölzle E, Bechara FG. Pathophysiology, clinical features and diagnosis of hyperhidrosis. Hautarzt 2012; 63: 448-51.
53. Schneier FR, Heimberg RG, Liebowitz MR, et al. Social anxiety and functioetnal impairment in patients seeking surgical evaluation for hyperhidrosis. Compr Psychiatry 2012; 7: 23-7.
54. Streker M, Kerscher M. Antiperspirants for the therapy of focal hyperhidrosis. Hautarzt 2012; 63: 452-5.
55. Hosp C, Naumann MK, Hamm H. Botulinum toxin in focal hyperhidrosis: an update. Hautarzt 2012; 63: 469-76.
56. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesther Dermatol 2011; 4: 32-8.
57. Brzezińska-Wcisło L, Wcisło-Dziadecka D, Bergler-Czop B. News in pathogenesis and therapy of seborrhoic dermatitis. Dermatol Prakt 2011; 4: 7-13.
58. Lis A, Wcisło-Dziadecka M, Kamińska G. Physiology and pathology of growth and loss of human scalp hair. Postep Derm Alergol 2003; 20: 260-6.
59. Braun-Falco O. Plewig G, Wolff HH, Burgdorf WHC. Inflammation of the skin. In: Dermatology. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC (eds). Czelej, Lublin 2002; 462-6.
60. Baran E, Szepietowski J, Maleszka R, et al. Seborrhoic dermatitis - therapuetic scheme. PDS recommendation. Dermatol Klin 2006; 4: 229-34.
61. Szepietowski J, Reich A. Treatment of skin and sexual transmitted disease. PZWL, Warsaw 2002.
62. Brzezińska-Wcisło L. What is new in the etiopathogenesis and treatment of dermatitis seborrhoica. Postep Derm Alergol 2005; 22: 10-3. (Pubitemid 40352936)
63. Wcisło-Dziadecka D, Lis-Świȩty A, Trzmiel D. Dandruff and seborrhoeic dermatitis of the scalp - pathogenesis, clinical picture and therapeutic aspects. Postep Derm Alergol 2007; 24: 59-64. (Pubitemid 46845299)
64. Czyż P, Ryglewska-Cho A, Miȩkoś-Zydek B, et al. News in pathogenesis and treatment of seborrhoic dermatitis. Nowa Klin 2003; 10: 1104-6.
65. Johnson B, Nunley J. Treatment of seborrheic dermatitis. Am Fam Physician 2000; 61: 2703-10. (Pubitemid 30337558)
66. Shin H, Kwon OS, Won CH, et al. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study. J Dermatol 2009; 36: 131-7.
67. Kerr K, Schwartz JR, Filloon T, et al. Scalp stratum corneum histamine levels: novel sampling method reveals association with itch resolution in dandruff/seborrhoeic dermatitis treatment. Acta Derm Venereol 2011; 21: 11-4.
68. Biber T. Other inflammation of the skin. In: Dermatology. Gliński W, Czarnecka-Operacz M, Krakowska D, et al. (eds). Czelej, Lublin 2010; 442-51.
69. Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology 2004; 208: 89-93. (Pubitemid 38446003)
70. Nowicki R. 1.5% cyclopiroxolamin shampoo in dandruff treatment. Przew Lek 2004; 9: 66-71.
71. Adamski Z. Dandruff as a dermatology problem. Mikol Lek 2002; 1: 21-4.
72. Zawirska A. Yeast of the genus Malassezia. New data. Postep Derm Alergol 2004; 21: 97-103.
73. Salomon J, Szepietowski J. Seborrhoic dermatitis - pathogenesis, clinics and therapy. Dermatol Klin 2006, 8: 127-31.
74. Gupta AK, Nicol KA. Seborrheic dermatotis of the scalp: etiology and treatment. J Drugs Dermatol 2004; 3: 155-8.
75. Nowicki R. Modern treatment of dandruff. Pol Merkuriusz Lek 2006; 20: 121-4.
76. Kostanecki W. Hair disease. PZWL, Warsaw 1979.
77. Lis-Świȩty A, Wcisło-Dziadecka D, Rogala-Poborska I, Trzmiel D. Congenital and acquired changes of hair structure. Postep Derm Alergol 2007; 24: 282-9.
78. Nowicka D, Reich A, Szepietowski J. Psychologic aspects of male androgenic alopecia. Dermatol Klin 2005; 7: 35-6.
79. Brzezińska-Wcisło L, Wcisło-Dziadecka D, Lis-Świȩty A, et al. What's new in pathogenesis and treatment of androgenic male alopecia. Dermatol Klin 2007; 9: 179-81.
80. Sawaya ME, Shapiro J. Androgenetic alopecia. Dermatol Clin 2000; 1: 47-61.
81. Hamilton JS. Patterned loss of hair in man, types and incidence. Ann N Y Acad Sci 1951; 53: 708-12.
82. Placek W, Kallas D, Czaplewski W, et al. Male androgenic alopecia. Świat Med Farm 2004; 5: 540-7.
83. Jabłońska S. Majewski S. Male androgenic alopecia. In: Skin disease and sexual transmitted disease. Jabłońska S, Majewski S (eds). PZWL, Warsaw 2005; 450-1.
84. Ryn HK, Kim KM, Yoo EA, et al. Evaluation of androgens in the scalp hair and plasma of patients with male - patttern baldness before and after finasteride administration. Br J Dermatol 2006; 154: 230-4.
85. Leavitt M, Perez-Meza D, Rao-Naveen A, et al. Effects of finasteride (1 mg) on hair transplant. Dermatol Surg 2005; 31: 1268-76. (Pubitemid 41587033)